Neola Medical has received a new patent approval in Europe for the Neola lung monitoring system. The patent specifically covers the probes that are attached to the chest and that enable continuous monitoring of the lungs. BioStock reached out to CEO Hanna Sjostrom to find out what significance the new patent has for the project.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.04 SEK | +0.99% | +2.51% | +4.62% |
1st Jan change | Capi. | |
---|---|---|
+4.62% | 13.25M | |
+73.23% | 12.38B | |
-21.02% | 7.81B | |
+6.76% | 6.72B | |
+12.78% | 5.39B | |
+38.73% | 5.03B | |
-16.79% | 4.72B | |
-22.01% | 4.06B | |
-30.24% | 2.68B | |
+54.25% | 2.59B |
- Stock Market
- Equities
- GPXMED Stock
- News Neola Medical AB
- Neola Medical Receives New Patent Approval in Europe for the Neola Lung Monitoring System